Key facts
- This page summarizes NIOWAVE, INC.'s Form 3 filing for Aptevo Therapeutics Inc. (APVO).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Jun 2026, 11:44.
NIOWAVE, INC. - 25 May 2026 Form 3 Insider Report for Aptevo Therapeutics Inc. (APVO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- APVO
- Reported as of
- 25 May 2026
- Net transaction value
- $0
- Reporting owner signature
- Jaime A Lerma
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
NIOWAVE, INC. filed Form 3 for Aptevo Therapeutics Inc. (APVO) on 22 Jun 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001666270
Primary reporting owner
NIOWAVE, INC.
- Relationship
- 10%+ Owner
- Address
- 1012 N. WALNUT STREET, LANSING
- Signature
- Jaime A Lerma
- Signature date
- 22 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APVO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 98,522
- Date
- 25 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APVO
holding
Derivative
Warrant (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 25 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 53,201
- Exercise price
- $8.00
* marks a reported price that did not pass the local price check.